Circulating tumor DNA (ctDNA) and circulating tumor cells (CTC) predictive value in HER2 negative metastatic breast cancer patients treated with first line weekly paclitaxel and bevacizumab: Results of a prospective cohort from the French Breast Cancer In

Affiliation auteurs!!!! Error affiliation !!!!
TitreCirculating tumor DNA (ctDNA) and circulating tumor cells (CTC) predictive value in HER2 negative metastatic breast cancer patients treated with first line weekly paclitaxel and bevacizumab: Results of a prospective cohort from the French Breast Cancer In
Type de publicationJournal Article
Year of Publication2019
AuteursPierga J-Y, Silveira A., Lorgis V., Tanguy M-L, Tredan O., Dubot C., Jacot W., Goncalves A., Debled M., Levy C., Ferrero J-M, Jouannaud C., Luporsi E., Mouret-Reynier M-A, Dalenc F., Lemonnier J., Berger F., Proudon C., Bidard F-C
JournalCANCER RESEARCH
Volume79
Date PublishedFEB
Type of ArticleMeeting Abstract
ISSN0008-5472
DOI10.1158/1538-7445.SABCS18-PD2-03